Lupin Pharmaceuticals Inc. is recalling one lot of Penicillamine Tablets USP (250 mg), a prescription medication used to treat conditions such as Wilson's disease and rheumatoid arthritis. The recall was issued because the tablets failed dissolution testing, meaning they may not dissolve at the correct rate to be effectively absorbed by the body. This specific recall involves 100-count bottles of the medication distributed to three wholesale or distributor accounts.
If the medication fails to dissolve properly, the patient may not receive the intended therapeutic dose, which could lead to reduced effectiveness in treating their underlying medical condition. No injuries or adverse events have been reported in connection with this specific defect.
You have 2 options:
Manufactured by Lupin Limited, Nagpur-441 108, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.